Literature DB >> 17699621

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases.

Daniel N Frank1, Allison L St Amand, Robert A Feldman, Edgar C Boedeker, Noam Harpaz, Norman R Pace.   

Abstract

The two primary human inflammatory bowel diseases, Crohn's disease (CD) and ulcerative colitis (UC), are idiopathic relapsing disorders characterized by chronic inflammation of the intestinal tract. Although several lines of reasoning suggest that gastrointestinal (GI) microbes influence inflammatory bowel disease (IBD) pathogenesis, the types of microbes involved have not been adequately described. Here we report the results of a culture-independent rRNA sequence analysis of GI tissue samples obtained from CD and UC patients, as well as non-IBD controls. Specimens were obtained through surgery from a variety of intestinal sites and included both pathologically normal and abnormal states. Our results provide comprehensive molecular-based analysis of the microbiota of the human small intestine. Comparison of clone libraries reveals statistically significant differences between the microbiotas of CD and UC patients and those of non-IBD controls. Significantly, our results indicate that a subset of CD and UC samples contained abnormal GI microbiotas, characterized by depletion of commensal bacteria, notably members of the phyla Firmicutes and Bacteroidetes. Patient stratification by GI microbiota provides further evidence that CD represents a spectrum of disease states and suggests that treatment of some forms of IBD may be facilitated by redress of the detected microbiological imbalances.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699621      PMCID: PMC1959459          DOI: 10.1073/pnas.0706625104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD.

Authors:  Patricia Lepage; Philippe Seksik; Malène Sutren; Marie-France de la Cochetière; Raymond Jian; Philippe Marteau; Joël Doré
Journal:  Inflamm Bowel Dis       Date:  2005-05       Impact factor: 5.325

Review 2.  Effects of dietary fiber on inflammatory bowel disease.

Authors:  Julio Galvez; M Elena Rodríguez-Cabezas; Antonio Zarzuelo
Journal:  Mol Nutr Food Res       Date:  2005-06       Impact factor: 5.914

3.  Diversity of the human intestinal microbial flora.

Authors:  Paul B Eckburg; Elisabeth M Bik; Charles N Bernstein; Elizabeth Purdom; Les Dethlefsen; Michael Sargent; Steven R Gill; Karen E Nelson; David A Relman
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

Review 4.  Commensal gut bacteria: mechanisms of immune modulation.

Authors:  Denise Kelly; Shaun Conway; Rustam Aminov
Journal:  Trends Immunol       Date:  2005-06       Impact factor: 16.687

Review 5.  Host-bacterial mutualism in the human intestine.

Authors:  Fredrik Bäckhed; Ruth E Ley; Justin L Sonnenburg; Daniel A Peterson; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 6.  Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans.

Authors:  H J Van Kruiningen
Journal:  Inflamm Bowel Dis       Date:  1999-08       Impact factor: 5.325

Review 7.  Crohn's disease: the case for bacteria.

Authors:  C Prantera; M L Scribano
Journal:  Ital J Gastroenterol Hepatol       Date:  1999-04

8.  Ribosomal DNA sequence analysis of mucosa-associated bacteria in Crohn's disease.

Authors:  Tom Prindiville; Mary Cantrell; Kenneth H Wilson
Journal:  Inflamm Bowel Dis       Date:  2004-11       Impact factor: 5.325

9.  Molecular inventory of faecal microflora in patients with Crohn's disease.

Authors:  Irène Mangin; Régis Bonnet; Philippe Seksik; Lionel Rigottier-Gois; Malène Sutren; Yoram Bouhnik; Christel Neut; Matthew D Collins; Jean-Frédéric Colombel; Philippe Marteau; Joël Doré
Journal:  FEMS Microbiol Ecol       Date:  2004-10-01       Impact factor: 4.194

10.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain.

Authors:  S Matsumoto; Y Okabe; H Setoyama; K Takayama; J Ohtsuka; H Funahashi; A Imaoka; Y Okada; Y Umesaki
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

View more
  1653 in total

Review 1.  Contributions of the intestinal microbiome in lung immunity.

Authors:  Jeremy P McAleer; Jay K Kolls
Journal:  Eur J Immunol       Date:  2017-08-31       Impact factor: 5.532

2.  Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes.

Authors:  Patrick Veiga; Carey Ann Gallini; Chloé Beal; Monia Michaud; Mary L Delaney; Andrea DuBois; Artem Khlebnikov; Johan E T van Hylckama Vlieg; Shivesh Punit; Jonathan N Glickman; Andrew Onderdonk; Laurie H Glimcher; Wendy S Garrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 3.  Gut microbiome, obesity, and metabolic dysfunction.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

4.  A breathtaking feat: to compete with the gut microbiota, Salmonella drives its host to provide a respiratory electron acceptor.

Authors:  Sebastian E Winter; Andreas J Bäumler
Journal:  Gut Microbes       Date:  2011 Jan-Feb

5.  Sampling of intestinal microbiota and targeted amplification of bacterial 16S rRNA genes for microbial ecologic analysis.

Authors:  Maomeng Tong; Jonathan P Jacobs; Ian H McHardy; Jonathan Braun
Journal:  Curr Protoc Immunol       Date:  2014-11-03

Review 6.  Microbial Degradation of Forensic Samples of Biological Origin: Potential Threat to Human DNA Typing.

Authors:  Hirak Ranjan Dash; Surajit Das
Journal:  Mol Biotechnol       Date:  2018-02       Impact factor: 2.695

7.  Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.

Authors:  Michael Davenport; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Ilseung Cho; P'ng Loke
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

Review 8.  Why related bacterial species bloom simultaneously in the gut: principles underlying the 'Like will to like' concept.

Authors:  Sebastian E Winter; Andreas J Bäumler
Journal:  Cell Microbiol       Date:  2013-12-16       Impact factor: 3.715

Review 9.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

10.  Effect of dietary copper level on the gut microbiota and its correlation with serum inflammatory cytokines in Sprague-Dawley rats.

Authors:  Feng Zhang; Weijiang Zheng; Rong Guo; Wen Yao
Journal:  J Microbiol       Date:  2017-09-02       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.